Sponsored by
Rep. Dingell, Debbie [D-MI-6]
ID: D000624
Follow the money
The bill
HR. 6005, 119th Congress — read as touching Health Insurance.
The sponsor
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
23 itemised contributions to this sponsor, pulled from FEC filings.
Track this bill's progress through the legislative process
Latest Action
Invalid Date
📍 Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
No summary available
Rep. Dingell, Debbie [D-MI-6]
Congress 119 • 2024 Election Cycle
No PAC contributions found
No committee contributions found
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 47 nodes and 23 connections (51 secondary connections hidden)
Total contributions: $75,900
Showing top 21 donors by contribution amount
Which industries are materially affected by specific provisions in this bill. 5 helped.
Section 2(c) establishes an interagency task force to conduct research on the diagnosis and treatment of health conditions of descendants of toxic-exposed veterans, which may lead to better healthcare outcomes and potentially reduced costs for health insurers.
Section 2(c) requires the Agency for Toxic Substances and Disease Registry to maintain a publicly available website with information on research activities and findings, which may facilitate collaboration between hospitals and health systems in treating toxic-exposed veterans and their descendants.
Section 2(c) requires research on the diagnosis and treatment of health conditions of descendants of toxic-exposed veterans, which may lead to the development of new treatments or medications.
Section 2(b) requires genomic sequencing and analysis to identify genetic markers associated with health issues in descendants of toxic-exposed veterans, which may involve biotechnology research and development.
Section 2(b) requires the collection of biological samples and health records, which may involve the use of medical devices for data collection and analysis.
For each industry this bill affects, here's what the sponsor (Rep. Dingell, Debbie [D-MI-6])received from donors associated with that industry during the 2022–present cycles. Donations are not proof of intent — they are a record of who funds the people writing the law.